Log in

Relevant bibliographies by topics / Varicellka vaccine

Contents

Journal articles
Dissertations / Theses
Books
Book chapters
Conference papers
Reports

Academic literature on the topic 'Varicellka vaccine'

Author: Grafiati

Published: 2 June 2025

Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Varicellka vaccine.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Varicellka vaccine"

1

Srinivas, G., D.V. Ramanjaneyulu, E. Muralinath, et al. "Indications, Mechanism of Action, Administration, Adverse Effects, Contra Indications, Relative Contra Indications and Toxicity MMR Vaccine." Research and Reviews: Neonatal and Pediatric Nursing 3, no. 2 (2025): 1–13. https://doi.org/10.5281/zenodo.15517148.

Full text

Abstract:

<em>Measles-containing vaccines are </em><em>accepted by the US Food and Drug Administration (FDA) and </em><em>utilized for the routine immunization of children and adolescents. These vaccines are also</em><em> highly recommended for adults born after 1970 who have not been immunized. Adults who were born prior to 1970 are typically considered to have developed a natural immunity to measles. In order to protect themselves from potential infection, vulnerable individuals, including healthcare workers, military people, and visitors from outside North America, should get the measles, mumps, and

APA, Harvard, Vancouver, ISO, and other styles

2

Srinivas, G., D.V. Ramanjaneyulu, E. Muralinath, et al. "A Fundamental Parameters of MMR Vaccine Include Indications, Mechanism of Action, Administration, Adverse Effects, Contra Indications, Relative Contra Indications and Toxicity." Journal of Research and Development in Pharmacological Practices 1, no. 1 (2025): 73–83. https://doi.org/10.5281/zenodo.15488368.

Full text

Abstract:

<em>As approved by the US Food and Drug Administration (FDA), measles-containing vaccinations are used to vaccinate children and adolescents on a regular basis. Adults born after 1970 who have not received these vaccinations are likewise strongly advised to do so. Adults born prior to 1970 are typically considered to have developed a natural immunity to measles. Regardless of the situation, vulnerable individuals, including healthcare workers, military people, and visitors from outside North America, should have the measles, mumps, and rubella (MMR) vaccine to protect against very high risk of

APA, Harvard, Vancouver, ISO, and other styles

3

Elizondo-Alzola, Usue, Mireia G. Carrasco, Laia Pinós, Camila Andrea Picchio, Cristina Rius, and Elia Diez. "Vaccine hesitancy among paediatric nurses: Prevalence and associated factors." PLOS ONE 16, no. 5 (2021): e0251735. http://dx.doi.org/10.1371/journal.pone.0251735.

Full text

Abstract:

Objective This study describes the prevalence of vaccine hesitancy associated with the Catalan systematic childhood vaccination calendar and some related psychosocial determinants among paediatric primary care nurses in Barcelona (Spain). Methods Cross-sectional descriptive study. In 2017 we invited the paediatric nurses (N = 165) working in Barcelona public primary health centres with paediatric departments (N = 41) to participate. They answered a questionnaire with sociodemographic and behavioural variables: severity and perceived probability of contracting the diseases of the vaccines in th

APA, Harvard, Vancouver, ISO, and other styles

4

Wang, Wei, Dequan Pan, Tong Cheng, and Hua Zhu. "Rational Design of a Skin- and Neuro-Attenuated Live Varicella Vaccine: A Review and Future Perspectives." Viruses 14, no. 5 (2022): 848. http://dx.doi.org/10.3390/v14050848.

Full text

Abstract:

Primary varicella-zoster virus (VZV) infection causes varicella, which remains a prominent public health concern in children. Current varicella vaccines adopt the live-attenuated Oka strain, vOka, which retains the ability to infect neurons, establish latency and reactivate, leading to vaccine-associated zoster in some vaccinees. Therefore, it is necessary to develop a safer next-generation varicella vaccine to help reduce vaccine hesitancy. This paper reviews the discovery and identification of the skin- and neuro-tropic factor, the open reading frame 7 (ORF7) of VZV, as well as the developme

APA, Harvard, Vancouver, ISO, and other styles

5

Tillieux, Sueli L., Wendy S. Halsey, Elizabeth S. Thomas, John J. Voycik, Ganesh M. Sathe, and Ventzislav Vassilev. "Complete DNA Sequences of Two Oka Strain Varicella-Zoster Virus Genomes." Journal of Virology 82, no. 22 (2008): 11023–44. http://dx.doi.org/10.1128/jvi.00777-08.

Full text

Abstract:

ABSTRACT Varicella-zoster virus (VZV) is a herpesvirus and is the causative agent of chicken pox (varicella) and shingles (herpes zoster). Active immunization against varicella became possible with the development of live attenuated varicella vaccine. The Oka vaccine strain was isolated in Japan from a child who had typical varicella, and it was then attenuated by serial passages in cell culture. Several manufacturers have obtained this attenuated Oka strain and, following additional passages, have developed their own vaccine strains. Notably, the vaccines Varilrix and Varivax are produced by

APA, Harvard, Vancouver, ISO, and other styles

6

Brunell, Philip A., Valerio M. Novelli, Susan V. Lipton, and Betsy Pollock. "Combined Vaccine Against Measles, Mumps, Rubella, and Varicella." Pediatrics 81, no. 6 (1988): 779–84. http://dx.doi.org/10.1542/peds.81.6.779.

Full text

Abstract:

A combined measles, mumps, rubella, and varicella vaccine produced seroconversions for all four components similar to that found if measles, mumps, and rubella vaccine or live varicella vaccine were given separately. In addition, those exposed to varicella were completely protected or had only a mild rash. Moreover, the reaction rates were not increased if the vaccines were combined. The somewhat lower and delayed serologic response to live varicella vaccine as compared with the combined measles, mumps, rubella, and varicella may have been due to the small amount of varicella vaccine virus use

APA, Harvard, Vancouver, ISO, and other styles

7

Aoki, Takahiro, Katsuyoshi Koh, Yutaka Kawano, et al. "Use of the Japanese Live Attenuated High-Titer Varicella Vaccine in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Recipients." Blood 124, no. 21 (2014): 2505. http://dx.doi.org/10.1182/blood.v124.21.2505.2505.

Full text

Abstract:

Abstract Background: Hematopoietic stem cell transplantation (HSCT) recipients carry a high risk of primary varicella and varicella-zoster virus (VZV) reactivation. VZV infections can be fatal, and VZV reactivation can be complicated by postherpetic neuralgia, which worsens the recipients’ post-HSCT quality of life. VZV vaccines may prevent such infections; however, international vaccination guidelines do not recommend VZV vaccination of HSCT recipients because few data regarding safety among HSCT recipients are available. In Japan, we use a high-titer Oka stain vaccine for varicella vaccinati

APA, Harvard, Vancouver, ISO, and other styles

8

Weinmann, Sheila, Stephanie Irving, Padma Koppolu, et al. "2767. Variation in Incidence of Pediatric Herpes Zoster by First- and Second-Dose Varicella Vaccine Formulations." Open Forum Infectious Diseases 6, Supplement_2 (2019): S975—S976. http://dx.doi.org/10.1093/ofid/ofz360.2444.

Full text

Abstract:

Abstract Background Varicella (VAR) and measles-mumps-rubella (MMR) vaccines are recommended for children at ages 12–15 months and 4–6 years. These are administered as separate MMR and VAR vaccines (MMR+VAR) or as combined measles-mumps-rubella-varicella (MMRV) vaccine. Herpes zoster (HZ), caused by wild-type or vaccine-strain varicella-zoster virus, can occur in children after varicella vaccination. It is unknown whether HZ incidence after varicella vaccination varies by vaccine formulation or simultaneous receipt of MMR. Methods Using data from six integrated health systems, we examined HZ i

APA, Harvard, Vancouver, ISO, and other styles

9

Cao, Han, Yunfei Wang, Ning Luan, and Cunbao Liu. "Immunogenicity of Varicella-Zoster Virus Glycoprotein E Formulated with Lipid Nanoparticles and Nucleic Immunostimulators in Mice." Vaccines 9, no. 4 (2021): 310. http://dx.doi.org/10.3390/vaccines9040310.

Full text

Abstract:

Theoretically, the subunit herpes zoster vaccine ShingrixTM could be used as a varicella vaccine that avoids the risk of developing shingles from vaccination, but bedside mixing strategies and the limited supply of the adjuvant component QS21 have made its application economically impracticable. With lipid nanoparticles (LNPs) that were approved by the FDA as vectors for severe acute respiratory syndrome coronavirus 2 vaccines, we designed a series of vaccines efficiently encapsulated with varicella-zoster virus glycoprotein E (VZV-gE) and nucleic acids including polyinosinic-polycytidylic aci

APA, Harvard, Vancouver, ISO, and other styles

10

Lee, Chanyeong, Minjee Kim, Jungmin Chun, et al. "Baculovirus Vector-Based Varicella-Zoster Virus Vaccine as a Promising Alternative with Enhanced Safety and Therapeutic Functions." Vaccines 12, no. 3 (2024): 333. http://dx.doi.org/10.3390/vaccines12030333.

Full text

Abstract:

Varicella-zoster virus (VZV) poses lifelong risks, causing varicella and herpes zoster (HZ, shingles). Currently, varicella and HZ vaccines are predominantly live attenuated vaccines or adjuvanted subunit vaccines utilizing VZV glycoprotein E (gE). Here, we propose our vaccine candidates involving a comparative analysis between recombinant baculoviral vector vaccines (AcHERV) and a live attenuated vaccine strain, vOka. AcHERV vaccine candidates were categorized into groups encoding gE only, VZV glycoprotein B (gB) only, or both gE and gB (gE-gB) as AcHERV-gE, AcHERV-gB, and AcHERV-gE-gB, respe

APA, Harvard, Vancouver, ISO, and other styles

More sources

Dissertations / Theses on the topic "Varicellka vaccine"

1

Hilleriteau, Caroline Imbert-Marcille Berthe Marie. "Le vaccin contre la varicelle état des connaissances en 2005 /." [S.l.] : [s.n.], 2005. http://theses.univ-nantes.fr/thesemed/PHhilleriteau.pdf.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Valentim, Joice. "Avaliações econômicas de programas de vacinação: as estimativas de custos em intervenções preventivas." Universidade de São Paulo, 2009. http://www.teses.usp.br/teses/disponiveis/5/5137/tde-19022010-164404/.

Full text

Abstract:

Esta tese representa o aprofundamento do estudo das estimativas de custos, componente integrante e determinante das avaliações econômicas, enquanto parte do projeto de pesquisa Estudos de custo-efetividade da incorporação de novas vacinas à rotina do Programa Nacional de Imunizações: Rotavírus, Varicela, Pneumocócica conjugada, Meningocócica C conjugada e Hepatite A desenvolvido por solicitação do Programa Nacional de Imunização/PNI da Secretaria de Vigilância em Saúde/SVS do Ministério da Saúde, a partir de 2005. A tese teve como objetivo analisar as condições de uso, dificuldades e repercuss

APA, Harvard, Vancouver, ISO, and other styles

3

Leung, May-bo Mabel, and 梁美寶. "The cost effectiveness of varicella vaccination program : a systemic review." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2014. http://hdl.handle.net/10722/206948.

Full text

Abstract:

Background Chickenpox is a common infectious disease among children. Ever since a live attenuated vaccine was developed in 1970s, different countries have adopted different vaccination program against chickenpox. Hong Kong recently has commenced a routine childhood varicella vaccination program. The objective of this study is to evaluate whether routine childhood varicella vaccination is cost effective and the implications to Hong Kong. Methodology Literature search was done on electronic databases: Medline and Embase for articles relevant to the topic. A total of 9 articles were retrieve

APA, Harvard, Vancouver, ISO, and other styles

4

KRAFFT, JEAN. "Donnees recentes sur le virus de la varicelle et du zona et notamment sur le vaccin anti-varicelle." Strasbourg 1, 1993. http://www.theses.fr/1993STR15010.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Bröms, Margareta. "Attitudes among Swedish medical personnel towarduniversal varicella vaccination and other new vaccines for children." Thesis, Nordic School of Public Health NHV, 2014. http://urn.kb.se/resolve?urn=urn:nbn:se:norden:org:diva-3639.

Full text

Abstract:

Background: Thea ttitudes, knowledge, and experience of health personnel regarding vaccines and preventable diseases contribute importantlyto the success of vaccination programs. Aim: This study aimed to valuate the opinions of healthpersonnel involved in the care of children on the introduction of various new and older vaccines to the Swedish childhood vaccination. We particularly examined the knowledge of varicella diseaseas chickenpox and shingles and attitudes toward the varicellavaccine. Method: We created and administered aquestionnaire on vaccineprioritization forseveral vaccines, inclu

APA, Harvard, Vancouver, ISO, and other styles

6

Hirose, Maki. "Atendimentos e internações de crianças e adolescentes com varicela em hospital geral antes da introdução da vacina varicela no Programa Nacional de Imunizações." Universidade de São Paulo, 2018. http://www.teses.usp.br/teses/disponiveis/5/5141/tde-31102018-132520/.

Full text

Abstract:

Introdução: Conhecida desde os tempos de Hipócrates, a varicela é autolimitada e isenta de complicações na maioria dos casos, mas responde por absenteísmo escolar das crianças e laboral dos cuidadores, além de hospitalizações e óbitos em pacientes previamente hígidos. Após a incorporação da vacina varicela no calendário americano em 1995, diversos países têm verificado suas epidemiologias para análise de custo-benefício da vacinação; alguns já vêm publicando resultados do impacto da vacina. O Brasil incluiu a vacina no calendário vacinal para crianças de 15 meses em 2013 e vem avaliando o seu

APA, Harvard, Vancouver, ISO, and other styles

7

Fagundes, Simone Nascimento. ""Levantamento da situação vacinal e avaliação sorológica para sarampo e varicela de crianças e adolescentes portadores de insuficiência renal crônica em tratamento conservador e dialítico"." Universidade de São Paulo, 2004. http://www.teses.usp.br/teses/disponiveis/5/5141/tde-24102005-151101/.

Full text

Abstract:

A infecção é causa de morbimortalidade no paciente com insuficiência renal crônica (IRC), facilitada pela uremia, que leva a resposta imune insuficiente, inclusive após a vacinação. Foram avaliadas a situação vacinal e a presença de anticorpos para sarampo e varicela, de 83 crianças e adolescentes com IRC. A adesão dos pacientes às vacinas foi BCG 100%, poliomielite 98,8%, DPT 97,6%, sarampo monovalente 96,4%, tríplice viral 88%, hepatite B 68,7%. Ausência de anticorpos para sarampo e varicela ocorreu em 14,5% e 26,5% dos pacientes. A susceptibilidade ao sarampo em vacinados, predominou acima

APA, Harvard, Vancouver, ISO, and other styles

8

El, Omari Kamel. "Etudes structurales et biochimiques de protéines cibles pour le développement de molécules antivirales et antitumorales." Paris 6, 2007. http://www.theses.fr/2007PA066024.

Full text

Abstract:

Le manque de thérapies efficaces contre différents cancers et virus a montré l’importance de comprendre les mécanismes impliqués dans les activités virales et tumorales et, également, de produire et caractériser des drogues spécifiques de protéines cibles. Pour développer des molécules efficaces, une synergie entre la chimie, la biologie, la biochimie et la biologie structurale est essentielle. Ce travail de thèse a pour but de définir des propriétés structurales de protéines qui pourraient aider au développement de nouvelles drogues et/ou à l’amélioration des molécules existantes. Nous nous s

APA, Harvard, Vancouver, ISO, and other styles

9

BOCCALINI, SARA. "Valutazione economica della vaccinazione anti-varicella neibambini e adolescenti italiani secondo differenti strategie diintervento: il peso dei casi ospedalizzati non complicati." Doctoral thesis, 2005. http://hdl.handle.net/2158/619182.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Huang, Jou-Fei, and 黃柔翡. "The Change of Taiwan Immunization System–Varicella and Pneumococcal Conjugate Vaccine Cases." Thesis, 2014. http://ndltd.ncl.edu.tw/handle/th8j97.

Full text

Abstract:

碩士<br>國立臺灣大學<br>政治學研究所<br>102<br>The success of Taiwan’s infectious disease control and eradication, as well as its hepatitis B prevention program, have been highly praised around the world. This success has been ascribed to the effective immunization structure – from the central government to local public health bureaus – that relies on good governance and cooperation to fulfill the goal of disease control. However, in the late 1990s, local governments started to promote their own vaccine policies, while the central government lagged behind and made no progress. What factors changed the well-

APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Varicellka vaccine"

1

Temte, Jonathan L., Mona Marin, Karen R. Broder, Dixie E. Snider, and Jane F. Seward. Use of combination measles, mumps, rubella, and varicella vaccine: Recommendations of the Advisory Committee on Immunization Practices. Dept. of Health and Human Services, Centers for Disease Control and Prevention, 2010.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

Picone, Olivier, Christelle Vauloup-Fellous, and Laurent Mandelbrot. Varicella-Zoster Virus. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190604813.003.0014.

Full text

Abstract:

Chickenpox in a pregnant woman is uncommon, but it is a major concern for patients and their families, as well as for clinicians caring for pregnant women. Varicella infection during pregnancy is usually benign, but there can be serious consequences for both mother and child. Notably, fetal varicella syndrome (FVS) can happen when infection occurs before 21 weeks of gestation. It can present with serious neurological anomalies and unusual cicatricial skin lesions. Later in pregnancy, primary neonatal varicella may occur when the mother is infected in the peripartum period, and it can be life-t

APA, Harvard, Vancouver, ISO, and other styles

3

Candido, Kenneth D., Teresa M. Kusper, and Nebojsa Nick Knezevic. Chronic Chest Wall Pain in Postherpetic Neuralgia. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190271787.003.0014.

Full text

Abstract:

Postherpetic neuralgia (PHN) is a debilitating condition that frequently arises after herpes zoster (HZ) caused by the varicella-zoster virus. It is characterized by severe neuropathic pain and sensory disturbances persisting after the resolution of characteristic vesicular skin lesions. Most commonly affected are the thoracic dermatomes. Trigeminal (V1), cervical, and lumbar nerves are other frequently affected sites. Early treatment shortens the duration of acute HZ and may prevent the onset of PHN. A variety of modalities are utilized to treat PHN, including chemical compounds, intervention

APA, Harvard, Vancouver, ISO, and other styles

4

Corlett, William Thomas. A Treatise On The Acute, Infectious Exanthemata; Including Variola, Rubeola, Scarlatina, Rubella, Varicella And Vaccinia. Kessinger Publishing, LLC, 2007.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

Corlett, William Thomas. A Treatise On The Acute, Infectious Exanthemata; Including Variola, Rubeola, Scarlatina, Rubella, Varicella And Vaccinia. Kessinger Publishing, LLC, 2007.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

6

Treatise on the Acute, Infectious Exanthemata: Including Variola, Rubeola, Scarlatina Rubella, Varicella, and Vaccinia, with Especial Reference to Diagnosis and Treatment. Creative Media Partners, LLC, 2023.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

Treatise on the Acute, Infectious Exanthemata: Including Variola, Rubeola, Scarlatina Rubella, Varicella, and Vaccinia, with Especial Reference to Diagnosis and Treatment. Creative Media Partners, LLC, 2023.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

Corlett, William Thomas. A Treatise on the Acute, Infectious Exanthemata; Including Variola, Rubeola, Scarlatina, Rubella, Varicella, and Vaccinia, With Especial Reference to Diagnosis and Treatment. Arkose Press, 2015.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

Corlett, William Thomas. A Treatise On the Acute, Infectious Exanthemata: Including Variola, Rubeola, Scarlatina Rubella, Varicella, and Vaccinia, With Especial Reference to Diagnosis and Treatment. Arkose Press, 2015.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Varicellka vaccine"

1

Bonville, Cynthia, and Manika Suryadevara. "Varicella and Shingles." In Vaccines. Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-58414-6_33.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Heath, R. B. "Varicella vaccines." In Recent Developments in Prophylactic Immunization. Springer Netherlands, 1989. http://dx.doi.org/10.1007/978-94-009-1067-6_6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Spoulou, Vana, Johannes Liese, and Timo Vesikari. "Varicella Vaccines." In Pediatric Vaccines and Vaccinations. Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-59952-6_10.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Spoulou, Vana, Johannes Liese, and Timo Vesikari. "Varicella Vaccines." In Pediatric Vaccines and Vaccinations. Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-77173-7_10.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Gershon, Anne A. "Varicella and Zoster." In Vaccines: A Biography. Springer New York, 2009. http://dx.doi.org/10.1007/978-1-4419-1108-7_15.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Gershon, Anne A. "Lessons from Varicella Vaccine." In Medical Virology 10. Springer US, 1991. http://dx.doi.org/10.1007/978-1-4615-3738-0_11.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Takahashi, Michiaki, Koichi Baba, Kiyoshi Horiuchi, Hitoshi Kamiya, and Yoshizo Asano. "A Live Varicella Vaccine." In Immunobiology and Prophylaxis of Human Herpesvirus Infections. Springer US, 1990. http://dx.doi.org/10.1007/978-1-4684-5853-4_6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Gershon, Anne A. "Live Attenuated Varicella Vaccine." In The Herpesviruses. Springer US, 1985. http://dx.doi.org/10.1007/978-1-4615-8021-8_15.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Gershon, Anne A. "Live Attenuated Varicella Vaccine." In Monographs in Virology. KARGER, 2006. http://dx.doi.org/10.1159/000096270.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Norrby, E. "Vaccines Against Measles, Mumps, Rubella, and Varicella." In Vaccines. Springer Berlin Heidelberg, 1999. http://dx.doi.org/10.1007/978-3-642-59955-2_5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Varicellka vaccine"

1

Bedford, Helen, Nicola Lingley-Heath, Jasmine Lai, and Sue Sherman. "455 Varicella vaccine: acceptability and preferences for administration by UK parents." In Royal College of Paediatrics and Child Health, Abstracts of the RCPCH Conference, Liverpool, 28–30 June 2022. BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health, 2022. http://dx.doi.org/10.1136/archdischild-2022-rcpch.329.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Kolundzic, Ivana, Elizabeth Whittaker, Zara Odetunde, and Rebekah Bingham. "8328 Understanding attitudes to the varicella vaccine in North West London: considerations for its introduction to the UK’s childhood vaccination schedule." In Royal College of Paediatrics and Child Health, Abstracts of the RCPCH Conference, Glasgow, 26 March 2025 – 28 March 2025. BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health, 2025. https://doi.org/10.1136/archdischild-2025-rcpch.486.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Iannetta, M., L. Benedetti, L. Coppola, et al. "P-205 Specific T-cell responses to varicella zoster virus glycoprotein E one year after vaccination with a recombinant adjuvanted subunit vaccine in people with multiple sclerosis on disease modifying treatments." In Abstracts from the 16° Italian Conference on AIDS and Antiviral Research. BMJ Publishing Group Ltd, 2024. http://dx.doi.org/10.1136/sextrans-icar-2024.262.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Benedetti, L., I. Fato, L. Coppola, et al. "P174 Multi-cytokine assessment of T-cell responses to varicella zoster virus glycoprotein E after vaccination with a recombinant adjuvanted subunit vaccine in patients with multiple sclerosis on immune modulating treatments." In Abstracts from the 17° Italian Conference on AIDS and Antiviral Research. BMJ Publishing Group Ltd, 2025. https://doi.org/10.1136/sextrans-icar-2025.207.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Varicellka vaccine"

1

Cronin, Conor, Christian Metzger, Daniel Pierce, and Grant Wallenfelsz. Examining Reported Side Effect Rates in Varicella and Hepatitis A Vaccines When Administered in Same vs. Different Locations in Pediatric Patients. Florida State University College of Medicine, 2019. http://dx.doi.org/10.17125/1561993470.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!